[The Value of Using SCAI Cardiogenic Shock Stages in Predicting Mortality in CICU Patients]

Danzengzhuoga1,2, Zhi-Feng Zhao1, Mao Chen1

  • 1Department of Cardiology, West China Hospital, Sichuan University, Chengdu 610041, China.

Insights

The Society of Cardiovascular Imaging and Intervention (SCAI) stages effectively predict mortality in cardiogenic shock (CS) patients admitted to the cardiac intensive care unit (CICU). Combining SCAI stages with GRACE scores improves risk prediction for acute coronary syndrome patients with CS.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Clinical Risk Stratification

Background:

  • Cardiogenic shock (CS) is a severe complication of cardiac dysfunction, associated with high mortality.
  • Accurate risk stratification is crucial for timely and effective management of CS patients.
  • The Society of Cardiovascular Imaging and Intervention (SCAI) developed a staging system for CS.

Purpose of the Study:

  • To evaluate the predictive value of the SCAI CS stages for in-hospital mortality in cardiac intensive care unit (CICU) patients.
  • To assess the added benefit of combining SCAI staging with the Global Registry of Acute Coronary Events (GRACE) score in predicting mortality for CS patients with acute coronary syndrome.

Main Methods:

  • Retrospective analysis of 839 CS patients admitted to a CICU between January 2011 and January 2018.
  • Patients were classified into SCAI stages C (Classic), D (Deteriorating), and E (Extremis).
  • Logistic regression and receiver operating characteristic (ROC) curve analysis were used to assess mortality prediction.

Main Results:

  • In-hospital mortality rates increased significantly across SCAI stages C (22.9%), D (44.0%), and E (53.6%) (P<0.001).
  • SCAI staging demonstrated an area under the curve (AUC) of 0.640 for predicting mortality, which improved to 0.776 after multivariate adjustment (P<0.001).
  • In acute coronary syndrome patients, combining SCAI stages with GRACE scores improved mortality prediction (AUC 0.702) compared to GRACE scores alone (AUC 0.644).

Conclusions:

  • SCAI CS stages provide a valuable tool for rapid risk stratification of CS patients upon admission to the CICU.
  • The combination of SCAI staging and GRACE scores enhances mortality risk prediction in CS patients with acute coronary syndrome.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
102
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
165
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
113
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
184
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
208
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
62